Evidence map›Paper›PMID 27997470›Full record

ArticleAnnals of surgery2018

Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.

Tarik Sammour, Songphol Malakorn, Brian K Bednarski, Harmeet Kaur, Ui Sup Shin, Craig Messick, Yi-Qian Nancy You, George J Chang

Abstract read
In one paragraph

Article in Annals of surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Role of minimally invasive surgery for rectal cancer.World journal of gastroenterology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tarik SammourDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Songphol MalakornDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Brian K BednarskiDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Harmeet KaurDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Ui Sup ShinDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Craig MessickDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Yi-Qian Nancy YouDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
George J ChangDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectiveThe aim of this study is to evaluate the oncological outcomes of robotic total mesorectal excision (TME) at an NCI designated cancer center. SUMMARY BACKGROUND DATA: The effectiveness of laparoscopic TME could not be established, but the robotic-assisted approach may hold some promise, with improved visualization and ergonomics for pelvic dissection. Oncological outcome data is presently lacking.

methodsPatients who underwent total mesorectal excision or tumor-specific mesorectal excision for rectal cancer between April 2009 and April 2016 via a robotic approach were identified from a prospective single-institution database. The circumferential resection margin (CRM), distal resection margin, and TME completeness rates were determined. Kaplan-Meier analysis of disease-free survival and overall survival was performed for all patients treated with curative intent.

resultsA total of 276 patients underwent robotic proctectomy during the study period. Robotic surgery was performed initially by 1 surgeon with 3 additional surgeons progressively transitioning from open to robotic during the study period with annual increase in the total number of cases performed robotically. Seven patients had involved circumferential resection margins (2.5%), and there were no positive distal or proximal resection margins. One hundred eighty-six patients had TME quality assessed, and only 1 patient (0.5%) had an incomplete TME. Eighty-three patients were followed up for a minimum of 3 years, with a local recurrence rate of 2.4%, and a distant recurrence rate of 16.9%. Five-year disease-free survival on Kaplan-Meier analysis was 82%, and 5-year overall survival was 87%.

conclusionsRobotic proctectomy for rectal cancer can be performed with good short and medium term oncological outcomes in selected patients.

Indexed as

Robotic Surgical ProceduresAdenocarcinomaFemaleHumansMaleMiddle AgedNeoplasm StagingProctectomyProspective StudiesRectal NeoplasmsSurvival AnalysisTreatment Outcome

Identifiers

PMID27997470
PMCPMC5498254
OpenAlexW2567149145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.